Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers to test if cannabis ingredient can help COPD patients

05.09.2005


Researchers from Imperial College London are looking for volunteers to test whether cannabinoids, the active ingredient of cannabis, can be used to alleviate the sensation of breathlessness caused by illnesses such as chronic obstructive pulmonary disease (COPD).

The team are looking for volunteers aged between 50 and 70, who don’t have breathing difficulties.

Dr Elspeth Pickering, clinical research fellow, from Imperial College London and Chelsea and Westminster Hospital, says: “Despite the best efforts of scientists for many years, no one has been able to develop a way to deal with the sensation of breathlessness without suppressing the drive to breathe. Breathlessness can have a major impact on the quality of life for patients with respiratory diseases, and by using a cannabinoid, we hope to find a way to block the mechanism which causes it.”



The researchers believe the cannabinoids could be used to reduce the sensation of breathlessness without depressing the respiratory system.

The study will take a morning on two different days, during which time volunteers will be hooked up to a circuit to regulate and measure their breathing. Carbon dioxide will be added to the air breathed by the volunteers, causing the sensation of breathlessness. This is a safe method of simulating breathlessness as the body naturally produces carbon dioxide.

Afterwards the volunteers will be given a spray which includes tetrahydrocannabinol (THC), the active ingredient in cannabis, which researchers hope will reduce the sensation of breathlessness.

Dr Anita Holdcroft from Imperial College London and Chelsea and Westminster Hospital, and study leader, adds: “The special formulation of the drug as a spray avoids the harmful effects of smoking cannabis. We hope the drug will stop the sensation of breathlessness, potentially providing a new way to deal with respiratory diseases.”

The study will be conducted at Charing Cross Hospital in west London. Volunteers will be paid for their time committed to the study. Volunteers aged between 50 and 70 who don’t have breathing difficulties and wish to take part should call 020 8846 1234 ext. 7055 to register their interest.

Tony Stephenson | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>